| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_366b28c3ff8b5387bea525036766190d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
| filingDate |
2008-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0396b4c22e604d24fbb439f13631085e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fefc23ff1ba422c97aab6ab96a8c7b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_516e01710d62f507127333148ec841b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a70856f0570c761e4c3c36535524121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f8b858dd2c1dd5a8be321ce052c412 |
| publicationDate |
2009-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2009009862-A |
| titleOfInvention |
DOSAGE FORMS OF LONG-TERM / PULSATILE RELEASE IN A SPECIFIC TIME. |
| abstract |
A dosage form of extended / pulsatile release at a specific time comprising; • a core comprising at least one active ingredient and at least one disintegrating agent; • a sealing layer surrounding the core that essentially consists of one or more water-soluble or water-independent pH independent polymers; • an outer coating essentially consisting of one or more pH independent polymers; wherein: at least one disintegrating agent is present in amounts of 1-20% by weight and at least one active ingredient is present in amounts of 1-80% by weight, relative to the core; the sealing layer is represented in 0.1-10% by weight, relative to the core; The outer coating is represented in 5-500% by weight, relative to the core. These covered nuclei are able to ensure the immediate release of the active substance after a pre-defined time interval, regardless of the physiological pH variations that occur in the gastrointestinal tract of mammals. |
| priorityDate |
2007-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |